FIELD: medicine.
SUBSTANCE: invention relates to medicine, specifically to clinical pharmacology, and can be used for pharmacological correction of diseases of the central nervous system. Described is the use of diterpene alkaloid N-oxide of 12-epinapelline as an agent having anticonvulsant activity.
EFFECT: invention allows extending the range of herbal products possessing manifested anticonvulsant activity and having no side effect.
1 cl, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT POSSESSING ANXIOLYTIC ACTIVITY | 2025 |
|
RU2838315C1 |
| 4-BENZOYLPYRIDINE OXIME DERIVATIVES HAVING ANTICONVULSANT ACTIVITY AS AGENTS FOR TREATMENT OF EPILEPSY AND PAROXYSMAL STATES | 2016 |
|
RU2643091C2 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING PAROXYSMAL CONDITIONS | 2011 |
|
RU2469722C1 |
| METHOD OF DETECTING ANTICONVULSANT ACTION OF SODIUM CITICOLINE AND VALPROATE WHEN APPLYING THEM TOGETHER ON MODEL OF ACUTE GENERALIZED CONVULSIONS CAUSED BY PENTYLENETETRAZOLE IN WISTAR MALE RATS | 2015 |
|
RU2600477C1 |
| DERIVATIVES OF 4-PHENYLPYRROLIDONE WITH ANTICONVULSANT AND NOOTROPIC ACTIVITY AS MEANS OF TREATING EPILEPSY AND PAROXYSMAL CONDITIONS | 2017 |
|
RU2748419C2 |
| AMINOALKYL DERIVATIVES OF DIBENZOFURANONE OXIME EXHIBITING ANTICONVULSANT ACTIVITY | 2020 |
|
RU2773021C2 |
| CINNAMOYL DERIVATIVES OF DIBENZOFURANONE OXIME WITH ANTICONVULSANT ACTIVITY | 2023 |
|
RU2810250C1 |
| COUMARIN, THIOCOUMARIN AND QUINOLINONE DERIVATIVES, HAVING ANTICONVULSANT ACTIVITY | 2017 |
|
RU2720510C2 |
| DIBENZOFURAN OXIME DERIVANTS WITH ANTICONVULSANT AND NEUROPROTECTIVE ACTIVITY | 2018 |
|
RU2744758C2 |
| ANTICONVULSANT MEDICAL PRODUCT | 2007 |
|
RU2361591C1 |
